BioSpace News Archive

Zogenix Reports Positive Results from Phase III Trial of Rare Childhood Epilepsy Study

Emeryville, California-based Zogenix announced positive topline data from its Phase III trial of Fintepla (fenfluramine) in Lennox-Gastaut Syndrome (LGS).

February 7, 2020

·

3 min read

·

Mark Terry

Drug Development

First Proof CRISPR Can Be Safe in Cancer Therapy

Although CRISPR gene editing is touted as likely to revolutionize medicine, the actual proof of its effectiveness and safety in treating diseases has been slow in coming. At least until now. Sort of.

February 7, 2020

·

3 min read

·

Mark Terry

Job Trends

Life Sciences Will Continue to Boom in Massachusetts - Will the Workforce Needs Be Met?

There’s a growing demand for life sciences professionals in Massachusetts, but a new report indicates that the home-grown talent pipeline is not adequate enough to meet the growing demands in the Bay State.

February 7, 2020

·

3 min read

·

Alex Keown

Business

Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes

It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.

February 7, 2020

·

6 min read

·

Mark Terry

Laboratory glassware containing chemical liquid, science research

Pharm Country

Clinical Catch-Up: February 3-7, 2020

Although it was a relatively slow week for clinical trial updates, there were still a number of announcements. Here’s a look.

February 7, 2020

·

5 min read

·

Mark Terry

Policy

Twist Settles Legal Battle With $22.5 Million Payment, No Admission of Wrongdoing

A four-year-old legal battle between Agilent Technologies and Twist Bioscience came to a conclusion Thursday. Twist agreed to pay Agilent $22.5 million to settle the lawsuit filed in 2016.

February 7, 2020

·

2 min read

·

Alex Keown

Bio NC

Despite Calls to Lower Drug Prices, More than 600 Medications Saw Increases in January

Even as lawmakers debate and malign proposed plans to lower the costs of prescription drugs in the United States, since the start of the year, prices have increased on more than 600 prescription drugs by an average of 5.2%.

February 7, 2020

·

2 min read

·

Alex Keown

Business

Illumina Taps Former FDA Commissioner Scott Gottlieb for Board of Directors Role

This morning, San Diego-based Illumina, Inc. announced that Gottlieb joined its board of directors effective Feb. 4.

February 7, 2020

·

2 min read

·

Alex Keown

Drug Development

Catalyst Biosciences Presents Positive Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) and Marzeptacog alfa (activated) (MarzAA) Programs at the 13th Annual EAHAD Congress

Enrollment in the DalcA trial is complete; results demonstrate DalcA provides Factor IX (FIX) activity exceeding the efficacy endpoint with no anti-drug antibodies

February 7, 2020

·

6 min read

Japan’s NEDO and Panasonic Achieve the World’s Highest Conversion Efficiency of 16.09% for Largest-area Perovskite Solar Cell Module

This Enables High Efficiency Solar Cell Power Generation in Places That Were Previously Difficult to Install

February 7, 2020

·

8 min read